Linda K Murphy, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Dane St, Beverly, MA 01915 Phone: 617-930-3735 Fax: 617-273-0814 |
Mrs. Candis Ann Bolden, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Dodge St, Beverly, MA 01915 Phone: 978-921-1182 |
Alaina Jayne Martens, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr Ste 350g, Beverly, MA 01915 Phone: 978-712-0003 |
Catlin Converse Khurana, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Suite 341d, Beverly, MA 01915 Phone: 617-930-3735 |
Karen Panella, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Suite 135 H, Beverly, MA 01915 Phone: 978-927-0172 Fax: 978-927-0179 |
Karolina Mazgaj Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Suite 343-g, Beverly, MA 01915 Phone: 978-712-0003 |
Larissa Kortis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Suite 343g, Beverly, MA 01915 Phone: 978-712-0003 |
Jilane Barros, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Cummings Ctr, Suite 3850, Beverly, MA 01915 Phone: 978-232-0332 Fax: 978-232-1103 |
Katherine Bonci Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Dodge St, Beverly, MA 01915 Phone: 978-921-1182 |
Mary Brennan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Dodge St, Beverly, MA 01915 Phone: 978-522-5842 |
Miss Kaiysa Mendy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Dodge St, Beverly, MA 01915 Phone: 978-921-1182 |
Ariel Hylton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Cummings Ctr Ste 3850, Beverly, MA 01915 Phone: 978-232-0332 Fax: 978-232-1103 |
Ms. Molly Corcoran, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Beverly, MA 01915 Phone: 978-927-0172 |
Miss Katherine Steiner, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Cummings Ctr, Suite 3850, Beverly, MA 01915 Phone: 978-232-0332 |
Carla Hendricks, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr Ste 135h, Beverly, MA 01915 Phone: 978-927-0172 |
Kayla Droogan, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 100 Cummings Ctr Ste 135h, Beverly, MA 01915 Phone: 978-927-0172 |
Mary Riotte Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Dodge St, Beverly, MA 01915 Phone: 978-921-1182 |
Tiffany Recor, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 55 Tozer Rd, Beverly, MA 01915 Phone: 518-420-6324 Fax: 518-882-0282 |
Mackenzie Morrow, MS SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr Ste 135c, Beverly, MA 01915 Phone: 978-473-7300 Fax: 978-969-0083 |
Ms. Megan E Anderson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Cummings Ctr, Suite 135h, Beverly, MA 01915 Phone: 978-927-0172 Fax: 978-927-0179 |
News Archive
Researchers at the University of Southampton have engineered cells with a 'built-in genetic circuit' that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
New research published in the July issue of the Journal of the American College of Surgeons shows that robotic telerounding may significantly reduce the length-of-stay of patients undergoing laparoscopic gastric bypass surgery if used to supplement standard postoperative visits, or rounds, made by surgeons.
The world is grappling with the worst pandemic in over 100 years. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus which emerged in China in December 2019 but has now spread across the globe. With a rapid rate of transmission, SARS-CoV-2 has now affected over 4.88 million people and resulted in over 322,000 deaths.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
The August issue of The American Journal of Gastroenterology includes clinical discussions of diet-associated NAFLD risk and increased risk of mortality from COVID-19 among PPI users.
› Verified 1 days ago